These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470 [Abstract] [Full Text] [Related]
9. Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant. Hamdan AH, Shaw NJ. Pediatr Pulmonol; 1998 Mar 12; 25(3):191-5. PubMed ID: 9556011 [Abstract] [Full Text] [Related]
14. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov 10; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [Abstract] [Full Text] [Related]
15. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Choukroun ML, Llanas B, Apere H, Fayon M, Galperine RI, Guenard H, Demarquez JL. Pediatr Pulmonol; 1994 Nov 10; 18(5):273-8. PubMed ID: 7898964 [Abstract] [Full Text] [Related]